# Emergent as 100% variant by day 70 post-infection of female immunocompromised 
# individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia. 
# Variant disappeared after convalescent plasma treatment (day 71) in subsequent patient sample sequencing.
# Avanzato et al. (2020) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640888/
K2N
